Zai Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Zai Lab
ZLAB Stock  USD 19.22  0.47  2.39%   
Zai Lab's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Zai Lab's valuation are provided below:
Gross Profit
269.1 M
Profit Margin
(0.38)
Market Capitalization
2.2 B
Enterprise Value Revenue
3.7601
Revenue
460.2 M
We have found one hundred twenty available fundamental gauges for Zai Lab, which can be analyzed and compared to other ratios and to its peers. All investors should make sure to confirm all of Zai Lab prevalent market performance against the performance between 2010 and 2026 to make sure the company can sustain itself down the road. The current year's Market Cap is expected to grow to about 2 B. The current year's Enterprise Value is expected to grow to about 1.4 B

Zai Lab Total Revenue

483.16 Million

Check Zai Lab financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Zai Lab's main balance sheet or income statement drivers, such as Depreciation And Amortization of 15.8 M, Interest Expense of 4.4 M or Selling General Administrative of 360.7 M, as well as many indicators such as Price To Sales Ratio of 3.96, Dividend Yield of 0.0 or PTB Ratio of 2.82. Zai financial statements analysis is a perfect complement when working with Zai Lab Valuation or Volatility modules.
  
Build AI portfolio with Zai Stock
Check out the analysis of Zai Lab Correlation against competitors.
For information on how to trade Zai Stock refer to our How to Trade Zai Stock guide.

Zai Lab Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets853.2 M1.2 B556.2 M
Slightly volatile
Other Current Liabilities32.2 M36.4 M21.6 M
Slightly volatile
Total Current Liabilities437 M416.2 M113.1 M
Slightly volatile
Other Liabilities25.8 M24.6 M9.8 M
Slightly volatile
Property Plant And Equipment Net46.2 M66.5 M30.1 M
Slightly volatile
Accounts Payable148.7 M141.6 M49.3 M
Slightly volatile
Cash480 M679.6 M314.4 M
Slightly volatile
Non Current Assets Total79.2 M153.1 M51.4 M
Slightly volatile
Cash And Short Term Investments674.6 M689.6 M440.4 M
Slightly volatile
Common Stock Total Equity3 K5.8 K2.8 K
Slightly volatile
Common Stock Shares Outstanding71.2 M109.5 M46.3 M
Slightly volatile
Liabilities And Stockholders Equity853.2 M1.2 B556.2 M
Slightly volatile
Non Current Liabilities Total29.6 M40.7 M34 M
Very volatile
Capital Surpluse887.2 M844.9 M412.9 M
Slightly volatile
Other Current Assets156.3 M148.9 M32.3 M
Slightly volatile
Other Stockholder Equity1.9 B3.3 B1.2 B
Slightly volatile
Total Liabilities479.7 M456.9 M147.9 M
Slightly volatile
Property Plant And Equipment Gross128.7 M122.6 M44.5 M
Slightly volatile
Preferred Stock Total Equity89.5 M154.7 M95.6 M
Slightly volatile
Total Current Assets774 M1 B504.7 M
Slightly volatile
Intangible Assets80 M76.1 M15.8 M
Slightly volatile
Common Stock4.9 K8.1 K3.4 K
Slightly volatile
Property Plant Equipment93.4 M89 M34.9 M
Slightly volatile
Non Currrent Assets Other7.7 M7 M7.2 M
Slightly volatile
Other Assets3.9 M4.1 M12.1 M
Pretty Stable
Long Term Investments5.3 M3.6 M3.2 M
Slightly volatile
Current Deferred Revenue26 M27.3 M1.3 B
Slightly volatile
Net Invested Capital846.3 M1.1 B574.4 M
Slightly volatile
Net Working Capital767.6 M863.8 M514.4 M
Slightly volatile
Short Term Debt247.5 M210.9 M1.2 B
Slightly volatile
Short and Long Term Debt Total235.5 M224.3 M43.4 M
Slightly volatile
Net Receivables111.4 M106.1 M28.6 M
Slightly volatile
Inventory78.5 M74.7 M18.1 M
Slightly volatile
Short and Long Term Debt159 M151.5 M59.3 M
Slightly volatile
Capital Stock5.9 K8.1 K4.7 K
Slightly volatile
Capital Lease Obligations19.6 M25 M17 M
Slightly volatile
Non Current Liabilities Other260 K292.5 K319.3 K
Slightly volatile

Zai Lab Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization15.8 M15 M5.1 M
Slightly volatile
Interest Expense4.4 M5.2 M3.4 M
Slightly volatile
Selling General Administrative360.7 M343.6 M114.1 M
Slightly volatile
Other Operating Expenses428.2 M689 M281.9 M
Slightly volatile
Research Development215.1 M220.9 M143.2 M
Slightly volatile
Total Operating Expenses347.9 M498.5 M229.9 M
Slightly volatile
Net Interest Income42.1 M40.1 M11.3 M
Slightly volatile
Interest Income44.8 M42.7 M11.8 M
Slightly volatile
Reconciled Depreciation14.3 M13.6 M4.6 M
Slightly volatile
Selling And Marketing Expenses74.3 M70.7 M26.6 M
Slightly volatile

Zai Lab Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation39.3 M65.6 M26.2 M
Slightly volatile
Begin Period Cash Flow423.2 M550.8 M276 M
Slightly volatile
Depreciation15.8 M15 M4.6 M
Slightly volatile
Capital Expenditures7.7 M8.1 M10.7 M
Slightly volatile
End Period Cash Flow500.6 M780.7 M327.8 M
Slightly volatile
Change To Netincome161.4 M153.7 M56.1 M
Slightly volatile
Dividends Paid12.8 M14.4 M15.8 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio3.964.16761.7 K
Slightly volatile
Days Sales Outstanding12293.6738179
Slightly volatile
Average Payables114.6 M109.1 M59.1 M
Slightly volatile
Stock Based Compensation To Revenue0.190.250.2208
Slightly volatile
Capex To Depreciation0.320.33975.1816
Slightly volatile
Inventory Turnover3.692.56067.161
Slightly volatile
Days Of Inventory On Hand220143122
Slightly volatile
Payables Turnover1.421.35150.4155
Slightly volatile
Sales General And Administrative To Revenue0.820.863.6795
Slightly volatile
Research And Ddevelopement To Revenue0.460.4801493
Slightly volatile
Capex To Revenue0.01670.017641.4877
Slightly volatile
Cash Per Share0.680.72085.2541
Pretty Stable
Days Payables Outstanding257270166.3 K
Slightly volatile
Income Quality0.620.8590.7245
Slightly volatile
Intangibles To Total Assets0.06820.06490.0145
Slightly volatile
Net Debt To EBITDA1.442.63181.4856
Slightly volatile
Current Ratio2.332.44926.3779
Very volatile
Receivables Turnover3.383.89652.8665
Slightly volatile
Debt To Equity0.350.33210.0668
Slightly volatile
Capex Per Share0.0070.00740.1389
Very volatile
Revenue Per Share0.820.42070.5326
Slightly volatile
Interest Debt Per Share0.220.22170.1383
Slightly volatile
Debt To Assets0.210.20270.0451
Slightly volatile
Operating Cycle342236301
Very volatile
Days Of Payables Outstanding257270166.3 K
Slightly volatile
Ebt Per Ebit1.060.77781.0086
Slightly volatile
Long Term Debt To Capitalization0.01470.01650.018
Slightly volatile
Total Debt To Capitalization0.260.24930.0545
Slightly volatile
Debt Equity Ratio0.350.33210.0668
Slightly volatile
Quick Ratio2.162.26966.302
Very volatile
Net Income Per E B T0.820.890.9912
Slightly volatile
Cash Ratio1.781.87324.9397
Pretty Stable
Days Of Inventory Outstanding220143122
Slightly volatile
Days Of Sales Outstanding12293.6738179
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.211.05371.098
Slightly volatile
Fixed Asset Turnover7.276.92651.7927
Slightly volatile
Debt Ratio0.210.20270.0451
Slightly volatile
Price Sales Ratio3.964.16761.7 K
Slightly volatile
Asset Turnover0.410.39310.1024
Slightly volatile
Gross Profit Margin0.720.58470.6593
Pretty Stable

Zai Lab Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap2 B1.9 B609.6 M
Slightly volatile

Zai Fundamental Market Drivers

Zai Upcoming Events

27th of February 2024
Upcoming Quarterly Report
View
14th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
27th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Zai Lab Financial Statements

Zai Lab stakeholders use historical fundamental indicators, such as Zai Lab's revenue or net income, to determine how well the company is positioned to perform in the future. Although Zai Lab investors may analyze each financial statement separately, they are all interrelated. For example, changes in Zai Lab's assets and liabilities are reflected in the revenues and expenses on Zai Lab's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Zai Lab. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue27.3 M26 M
Total Revenue460.2 M483.2 M
Cost Of Revenue190.5 M200 M
Stock Based Compensation To Revenue 0.20  0.19 
Sales General And Administrative To Revenue 0.86  0.82 
Research And Ddevelopement To Revenue 0.48  0.46 
Capex To Revenue 0.02  0.02 
Revenue Per Share 0.42  0.82 
Ebit Per Revenue(0.50)(0.52)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
FSLYFastly Class A
MOBMobilicom Limited American
CMGChipotle Mexican Grill
When determining whether Zai Lab offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Zai Lab's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Zai Lab Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Zai Lab Stock:
How To Invest In Zai
Details
Is Zai Stock a good investment?
Details
What is Zai Lab's Net Worth?
Details
Largest Biotechnology Companies
View
Largest Pharmaceuticals, Biotechnology & Life Sciences Companies
View
Check out the analysis of Zai Lab Correlation against competitors.
For information on how to trade Zai Stock refer to our How to Trade Zai Stock guide.
You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zai Lab. Anticipated expansion of Zai directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Zai Lab assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share
(1.90)
Revenue Per Share
4.201
Quarterly Revenue Growth
0.17
Return On Assets
(0.12)
Return On Equity
(0.23)
The market value of Zai Lab is measured differently than its book value, which is the value of Zai that is recorded on the company's balance sheet. Investors also form their own opinion of Zai Lab's value that differs from its market value or its book value, called intrinsic value, which is Zai Lab's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zai Lab's market value can be influenced by many factors that don't directly affect Zai Lab's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Please note, there is a significant difference between Zai Lab's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zai Lab is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Zai Lab's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY